Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

$ADMAPress releaseJul 29, 2026, 9:39 AM ETRead the release

Bernstein Liebhard LLP reminded investors of the August 10, 2026 deadline to join a securities fraud class action lawsuit against ADMA Biologics. The lawsuit alleges ADMA made materially false statements regarding business operations and financial stability between August 9, 2024 and March 25, 2026.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.